Astrocytes in Dementia with Lewy Bodies (DLB) represent a specialized reactive astrocyte population that plays a complex role in the pathogenesis of this second most common neurodegenerative dementia. These cells respond to alpha-synuclein pathology, Lewy body formation, and associated neuroinflammation, adopting both neuroprotective and potentially neurotoxic phenotypes depending on disease stage and individual factors[1].
Unlike Alzheimer's disease where astrocyte involvement has been extensively characterized, research into astrocyte pathology in DLB is still emerging. However, it is increasingly clear that astrocytes contribute significantly to disease progression through their roles in protein clearance, neuroinflammation, and neuronal support.
Dementia with Lewy bodies is characterized by:
Astrocytes in DLB interact with these pathological features in complex ways.
Astrocytes can internalize extracellular alpha-synuclein through multiple mechanisms[2]:
DLB brains show A1-reactive astrocytes characterized by:
Some astrocytes adopt a potentially protective phenotype:
Astrocytes in DLB contribute to neuroinflammation through:
Many DLB cases show AD co-pathology:
DLB shares features with PD:
| Strategy | Target | Development Stage |
|---|---|---|
| Anti-inflammatory agents | Cytokine production | Research |
| Alpha-synuclein clearance | Lysosomal enhancement | Preclinical |
| Neurotrophic support | BDNF/GDNF induction | Research |
| Metabolic modulation | Lactate transport | Experimental |
Converting reactive astrocytes to neuroprotective phenotype:
The study of Astrocytes In Dementia With Lewy Bodies has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brück D, et al. Astrocytes in Lewy body disease: Friends or foes? Acta Neuropathol. 2016. 2016. ↩︎
Latreille M, et al. Alpha-synuclein in astrocytes: Implications for neurodegeneration. Neurobiol Dis. 2022. 2022. ↩︎